A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Summary

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Inflammatory Bowel Disease (IBD)
• Ulcerative Colitis (UC)
• Crohn's Disease

Eligibility basics and study details

Study type

Interventional

Phase

Phase 2

Ages

18 to 80 years

Sex

All

Healthy volunteers

Not accepted

Sponsor

Mirador Therapeutics, Inc.

Last updated on ClinicalTrials.gov

March 12, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites